Protein-protein interaction modulation
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- TAROS CHEMICALS GMBH & CO KG
German chemistry SME providing contract synthesis, compound libraries, and high-throughput screening for pharmaceutical and biotech R&D consortia.
“TASPPI (2016-2020) worked on small-molecule stabilisation of protein-protein interactions, a challenging frontier in drug design.”
SMEDE4 projects - LEAD DISCOVERY CENTER GMBH
German drug discovery SME translating academic biomedical research into validated lead compounds, specializing in DNA repair targets and protein-protein interactions.
“TASPPI specifically targeted small-molecule stabilisation of protein-protein interactions, a frontier area in drug design.”
PrimarySMEDE4 projects - CELLTECH R&D LIMITED
UK biotech company specializing in microbial protein expression and secretion systems for biotherapeutics and industrial enzyme production.
“TASPPI project (2016-2020) addressed small-molecule stabilisation of protein-protein interactions, complementing their core protein engineering work.”
UK3 projects